Form EFFECT KalVista Pharmaceuticals
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 19, 2024 4:30 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Microchip Technology, in Collaboration With Micron Technology, Demonstrates High-Performance PCIe® Gen 6 Storage Architecture for AI and Data Center Infrastructure
- Bazooka Brands® Launches "The Great Candy Battle: MomTok Edition," Pitting Creators Jessi Draper and Mayci Neeley Against Each Other in a Month-Long Sales Showdown
- BESS 903 Project Passes Major Permitting Milestone, Advancing PowerBank's Ontario Battery Storage Pipeline
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
